Jeonjinbio Co., Ltd. (KOSDAQ:110020)
South Korea · Delayed Price · Currency is KRW 1,995.00
+23.00 (1.17%)
At close: Aug 24, 2026
Jeonjinbio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18,072 | 22,828 | 21,288 | 60,093 | 25,582 | 34,243 | |
Market Cap Growth | -41.32% | 7.23% | -64.58% | 134.91% | -25.30% | -48.24% |
Enterprise Value | 11,015 | 17,144 | 15,567 | 63,882 | 28,671 | 29,482 |
Last Close Price | 1995.00 | 2520.00 | 2350.00 | 8030.00 | 3740.00 | 5400.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 1086.28 | - | 4.90 | - | - | - |
PS Ratio | 1.25 | 1.67 | 1.11 | 3.83 | 3.28 | 10.65 |
PB Ratio | 1.05 | 1.31 | 1.21 | 9.66 | 2.67 | 3.17 |
P/TBV Ratio | 1.05 | 1.31 | 1.21 | 9.78 | 2.70 | 3.19 |
P/FCF Ratio | 17.53 | - | 8.14 | - | - | - |
P/OCF Ratio | 10.64 | 47.25 | 7.08 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.76 | 1.25 | 0.81 | 4.07 | 3.68 | 9.17 |
EV/EBITDA Ratio | 22.60 | 88.97 | 6.23 | 108.19 | - | - |
EV/EBIT Ratio | - | - | 13.44 | - | - | - |
EV/FCF Ratio | 10.68 | - | 5.95 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | 0.01 | 0.90 | 0.62 | 0.69 |
Debt / EBITDA Ratio | - | - | 0.04 | 9.48 | - | - |
Debt / FCF Ratio | - | - | 0.04 | - | - | - |
Net Debt / Equity Ratio | -0.41 | -0.37 | -0.38 | 0.39 | 0.48 | -0.73 |
Net Debt / EBITDA Ratio | -14.48 | -33.28 | -2.66 | 4.08 | -2.65 | 2.97 |
Net Debt / FCF Ratio | -6.84 | 20.96 | -2.54 | -2.51 | -0.81 | 1.87 |
Asset Turnover | 0.79 | 0.73 | 1.05 | 0.88 | 0.37 | 0.15 |
Inventory Turnover | 8.17 | 10.40 | 9.95 | 5.83 | 4.52 | 4.02 |
Quick Ratio | 9.13 | 9.66 | 8.47 | 0.54 | 0.26 | 1.11 |
Current Ratio | 10.49 | 10.83 | 9.34 | 0.69 | 0.60 | 1.16 |
Return on Equity (ROE) | 0.10% | -1.12% | 36.40% | -81.59% | -30.58% | -19.10% |
Return on Assets (ROA) | -0.22% | -1.15% | 3.96% | -4.37% | -9.17% | -8.70% |
Return on Capital Employed (ROCE) | -0.40% | -1.90% | 6.50% | -19.20% | -31.40% | -28.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.09% | -0.86% | 20.42% | -10.72% | -12.17% | -6.16% |
FCF Yield | 5.71% | -1.34% | 12.29% | -1.60% | -22.30% | -12.36% |
Buyback Yield / Dilution | -1.27% | -5.26% | -18.14% | -10.69% | -6.14% | -27.16% |